A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland
Switzerland, 2021 - 2022
Reference ID
10.16909-dataset-54
Producer(s)
GENTON, Blaise
Collections
Department of Ambulatory Care (DDP)